Find what you’re looking for:

icon icon

WHO WE ARE

adMare BioInnovations is Canada’s Global Life Sciences Venture, building the Canadian life sciences industry from sea to sea. We do this by sourcing therapeutically and commercially promising research from leading academic and biotech partners to create new companies of scale, providing specialized expertise, infrastructure, and capital to help existing companies scale up, and driving the growth of those companies into Canadian anchors by training the next generation of highly-qualified personnel.

 

WHAT WE DO

We work with academic researchers to translate leading research into new companies of scale

adMare offers a pathway to advance their breakthrough research, and translate it into a new life sciences company, and new therapeutics for patients.

LEARN MORE

 

WHAT WE DO

 

We work with existing life sciences companies to help them scale-up

adMare is a single-stop destination with the necessary scientific, business, infrastructure, and capital resources, including the adMare Innovation Centre, to drive health-related technology to a company of scale.

LEARN MORE

 

We train the next generation of highly-qualified personnel to drive the growth of companies into strong anchors

The adMare Academy offers unique and valuable training experiences and a pathway to a successful industry career.

LEARN MORE

LATEST NEWS

Unleashing Canada’s Radiopharmaceutical Excellence

September 17 2020

New Pan-Canadian Partnership Looks to Commercialize the Country’s Most Promising Radiopharmaceutical Innovations September 17,...

Read More

Global Pandemic Drives Unprecedented Need to Grow Canada’s Life Science Leadership

September 14 2020

adMare Academy Announces New Executive Institute Cohort Vancouver and Montreal, Canada – September 14,...

Read More

adMare is pleased to increase our investment in Inversago Pharma alongside leading life sciences investors and be a part of building this exceptional Canadian company developing innovative therapies

September 08 2020

Inversago Pharma closes US$35M Series B financing round and expands Board of Directors Vancouver...

Read More
View all news

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse scelerisque aliquet odio, nec gravida magna blandit aliquet.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse scelerisque aliquet odio, nec gravida magna blandit aliquet. Pellentesque cursus orci eu est tempor mattis. Sed pulvinar vehicula lectus, et blandit risus. Sed consequat, est in pharetra suscipit, libero urna venenatis ex, nec tristique nisi leo eu arcu. Proin euismod venenatis diam, sit amet maximus lorem condimentum nec. Sed vehicula, metus sollicitudin viverra interdum, mi purus sodales nisi, ornare tempus ex tellus dignissim erat. Suspendisse maximus accumsan scelerisque. Aliquam dapibus turpis id ultrices bibendum. Vestibulum nulla justo, facilisis vitae feugiat in, elementum et elit.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse scelerisque aliquet odio, nec gravida magna blandit aliquet. Pellentesque cursus orci eu est tempor mattis. Sed pulvinar vehicula lectus, et blandit risus. Sed consequat, est in pharetra suscipit, libero urna venenatis ex, nec tristique nisi leo eu arcu. Proin euismod venenatis diam, sit amet maximus lorem condimentum nec. Sed vehicula, metus sollicitudin viverra interdum, mi purus sodales nisi, ornare tempus ex tellus dignissim erat. Suspendisse maximus accumsan scelerisque. Aliquam dapibus turpis id ultrices bibendum. Vestibulum nulla justo, facilisis vitae feugiat in, elementum et elit.